KL1333

· Abliva AB

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KL1333, covering 2018-04-27 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease [Phase 2]